The first 100 patients have been enrolled in a clinical trial investigating a novel light therapy device intended to treat individuals with Parkinson’s disease, according to the manufacturer.Enrollees are expected to use the Celeste device within their own homes for 1 hour per day when doing activities like reading, eating or watching TV.
The study’s primary endpoints are improvements in overall quality of life, motor function, sleep quality, mood and cognition, evaluated by clinical scales and patient-reported outcomes